Non-invasive Glioma Characterization Through Molecular Imaging

Description

MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.

Conditions

Glioma, Brain Tumor, Primary Brain Tumor, Malignant Glioma, Malignant Primary Brain Tumor

Study Overview

Study Details

Study overview

MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.

Pilot Study for Non-invasive Glioma Characterization Through Molecular Imaging

Non-invasive Glioma Characterization Through Molecular Imaging

Condition
Glioma
Intervention / Treatment

-

Contacts and Locations

Miami

University of Miami, Miami, Florida, United States, 33136

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adults (≥18 year old)
  • * Subjects with suspected or confirmed gliomas and who will have a medically indicated biopsy or resection of his/her brain lesion.
  • * Adults unable to consent
  • * Individuals who are not yet adults (infants, children, teenagers)
  • * Pregnant women
  • * Patients unable to have MRI done

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Miami,

Macarena De La Fuente, MD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

2025-01